Dr. Anish Koka's Newsletter

Medicine, Cardiology and health policy

By Anish Koka MD (Cardiology)

· Over 3,000 subscribers

Fire the Regulator. Approve the Drug.

The FDA fired its acting drug chief after she blocked approval of an immune-suppressing drug for children.

Jun 21 | Anish Koka MD (Cardiology)

They Were Fixing the FDA. Then They Were Pushed Out.

On January 12, 2026, the FDA approved Zycubo — copper histidinate — for Menkes disease.

Jun 3 | Anish Koka MD (Cardiology)

Pennsylvania Had a Functioning Medical Malpractice Market. Then It Didn't.

What eighteen years of NAIC financials reveal about a reform regime that worked, and the judicial order that ended it.

May 31 | Anish Koka MD (Cardiology)

Follow up to MIS-C post: Response from a Pediatric Immunologist

A follow up FAQ

May 17 | Anish Koka MD (Cardiology)

Did MIS-C Ever Really Exist?

How a clinical syndrome with no specific test became a generation-defining pediatric emergency, and then quietly vanished.

May 16 | Anish Koka MD (Cardiology)

When the Data Doesn't Hold Up: Inside Replimune's Second FDA Rejection

A small biotech, an oncolytic virus, and a four-year regulatory story that's now ending in a media campaign instead of a randomized trial.

May 6 | Anish Koka MD (Cardiology)

The Economists Who Saw Medicare Coming

What Buchanan, Tullock, and Hayek understood in 1962 that we're still pretending not to understand in 2026.

Apr 25 | Anish Koka MD (Cardiology)

America Has Solved the Hardest Healthcare Access Problem Better Than Anyone Else — Here’s the Data

A bivariate analysis of 84,000 census tracts reveals that only 2% of Americans live beyond guideline-recommended access to emergency cardiac care.

Apr 12 | Anish Koka MD (Cardiology)